Breaking News Instant updates and real-time market news.

NKRKY

Nokian Renkaat

$5.11 /

+0.11 (+2.20%)

14:59
08/24/22
08/24
14:59
08/24/22
14:59

Nokian Renkaat price target lowered to EUR 11.50 from EUR 12.80 at JPMorgan

JPMorgan analyst Akshat Kacker lowered the firm's price target on Nokian Renkaat to EUR 11.50 from EUR 12.80 and keeps a Neutral rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Downgrade
Achilles Therapeutics downgraded to Perform from Outperform at Oppenheimer » 21:45
12/06/22
12/06
21:45
12/06/22
21:45
ACHL

Achilles Therapeutics

$1.50 /

-0.215 (-12.57%)

Oppenheimer analyst Mark…

Oppenheimer analyst Mark Breidenbach downgraded Achilles Therapeutics to Perform from Outperform without a price target after the company presented new clinical data from the ongoing CHIRON and THETIS trials of its clonal neoantigen T-cell therapy. With no clear efficacy advantage for clonal neoantigen T-cells over conventional tumor-infiltrating lymphocytes, Achilles must make "significant optimizations before cNeTs could become commercially viable," Breidenbach tells investors in a research note. He moved to the sidelines pending "more convincing clinical proof-of-concept."

ShowHide Related Items >><<
ACHL Achilles Therapeutics
$1.50 /

-0.215 (-12.57%)

ACHL Achilles Therapeutics
$1.50 /

-0.215 (-12.57%)

16:19 Today Piper Sandler
Achilles Therapeutics price target lowered to $8 from $10 at Piper Sandler
15:11 Today Chardan
Achilles Therapeutics price target lowered to $17 from $20 at Chardan
05/27/22 Piper Sandler
Achilles Therapeutics price target lowered to $10 from $17 at Piper Sandler
05/10/22 Piper Sandler
Achilles Therapeutics price target lowered to $17 from $20 at Piper Sandler
ACHL Achilles Therapeutics
$1.50 /

-0.215 (-12.57%)

Downgrade
M&T Bank downgraded to Market Perform from Outperform at Keefe Bruyette » 21:07
12/06/22
12/06
21:07
12/06/22
21:07
MTB

M&T Bank

$160.43 /

-0.9 (-0.56%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTB M&T Bank
$160.43 /

-0.9 (-0.56%)

MTB M&T Bank
$160.43 /

-0.9 (-0.56%)

12/05/22 Morgan Stanley
M&T Bank assumed with an Overweight at Morgan Stanley
10/21/22 Citi
M&T Bank price target lowered to $180 from $200 at Citi
10/20/22 Wedbush
M&T Bank price target lowered to $170 from $187 at Wedbush
10/20/22 Piper Sandler
M&T Bank price target lowered to $195 from $210 at Piper Sandler
MTB M&T Bank
$160.43 /

-0.9 (-0.56%)

MTB M&T Bank
$160.43 /

-0.9 (-0.56%)

MTB M&T Bank
$160.43 /

-0.9 (-0.56%)

Hot Stocks
Five Below director sells $9.1M, CEO sells $1.9M in common stock » 21:02
12/06/22
12/06
21:02
12/06/22
21:02
FIVE

Five Below

$180.62 /

-2.7 (-1.47%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FIVE Five Below
$180.62 /

-2.7 (-1.47%)

FIVE Five Below
$180.62 /

-2.7 (-1.47%)

12/02/22 Deutsche Bank
Five Below price target lowered to $201 from $205 at Deutsche Bank
12/01/22 Truist
Five Below price target raised to $196 from $161 at Truist
12/01/22 Craig-Hallum
Five Below price target raised to $200 from $178 at Craig-Hallum
12/01/22 Evercore ISI
Five Below price target raised to $170 from $155 at Evercore ISI
FIVE Five Below
$180.62 /

-2.7 (-1.47%)

FIVE Five Below
$180.62 /

-2.7 (-1.47%)

FIVE Five Below
$180.62 /

-2.7 (-1.47%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
12/06/22
12/06
20:25
12/06/22
20:25
BF.B

Brown-Forman

$73.70 /

-0.29 (-0.39%)

, BF.A

Brown-Forman

$73.23 /

-0.64 (-0.87%)

, CPB

Campbell Soup

$52.99 /

-0.325 (-0.61%)

, ASO

Academy Sports

$49.31 /

+1.015 (+2.10%)

, OLLI

Ollie's Bargain Outlet

$57.74 /

+0.41 (+0.72%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Brown-Forman (BF.B), consensus 55c... Campbell Soup (CPB), consensus 88c... Academy Sports and Outdoors (ASO), consensus $1.59... Ollie's Bargain Outlet (OLLI), consensus 41c.

ShowHide Related Items >><<
BF.B Brown-Forman
$73.70 /

-0.29 (-0.39%)

BF.A Brown-Forman
$73.23 /

-0.64 (-0.87%)

CPB Campbell Soup
$52.99 /

-0.325 (-0.61%)

ASO Academy Sports
$49.31 /

+1.015 (+2.10%)

OLLI Ollie's Bargain Outlet
$57.74 /

+0.41 (+0.72%)

BF.B Brown-Forman
$73.70 /

-0.29 (-0.39%)

10/10/22 Wedbush
Brown-Forman initiated with a Neutral at Wedbush
10/10/22 Wedbush
Brown-Forman initiated with a Neutral at Wedbush
09/28/22 Truist
Brown-Forman reinstated with a Buy at Truist
08/25/22 Barclays
Brown-Forman price target raised to $73 from $72 at Barclays
BF.A Brown-Forman
$73.23 /

-0.64 (-0.87%)

10/10/22 Wedbush
Brown-Forman initiated with a Neutral at Wedbush
10/10/22 Wedbush
Brown-Forman initiated with a Neutral at Wedbush
CPB Campbell Soup
$52.99 /

-0.325 (-0.61%)

11/15/22 Exane BNP Paribas
Campbell Soup initiated with an Underperform at Exane BNP Paribas
09/13/22 UBS
Campbell Soup's top-line guidance may be hard to achieve, says UBS
09/02/22 Piper Sandler
Campbell Soup price target lowered to $46 from $47 at Piper Sandler
08/25/22 JPMorgan
Campbell Soup price target raised to $49 from $46 at JPMorgan
ASO Academy Sports
$49.31 /

+1.015 (+2.10%)

11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
09/09/22 Loop Capital
Academy Sports initiated with a Buy at Loop Capital
09/08/22 UBS
Academy Sports price target raised to $60 from $55 at UBS
09/08/22 Evercore ISI
Academy Sports price target raised to $60 from $55 at Evercore ISI
OLLI Ollie's Bargain Outlet
$57.74 /

+0.41 (+0.72%)

10/24/22 Gordon Haskett
Ollie's Bargain Outlet initiated with a Buy at Gordon Haskett
09/16/22 JPMorgan
Ollie's Bargain Outlet price target raised to $54 from $40 at JPMorgan
09/02/22 Truist
Ollie's Bargain Outlet price target raised to $50 from $40 at Truist
08/30/22 Citi
Citi cautious into Ollie's results, opens 'negative catalyst watch'
BF.B Brown-Forman
$73.70 /

-0.29 (-0.39%)

BF.A Brown-Forman
$73.23 /

-0.64 (-0.87%)

CPB Campbell Soup
$52.99 /

-0.325 (-0.61%)

ASO Academy Sports
$49.31 /

+1.015 (+2.10%)

OLLI Ollie's Bargain Outlet
$57.74 /

+0.41 (+0.72%)

BF.B Brown-Forman
$73.70 /

-0.29 (-0.39%)

BF.A Brown-Forman
$73.23 /

-0.64 (-0.87%)

CPB Campbell Soup
$52.99 /

-0.325 (-0.61%)

ASO Academy Sports
$49.31 /

+1.015 (+2.10%)

CPB Campbell Soup
$52.99 /

-0.325 (-0.61%)

ASO Academy Sports
$49.31 /

+1.015 (+2.10%)

OLLI Ollie's Bargain Outlet
$57.74 /

+0.41 (+0.72%)

CPB Campbell Soup
$52.99 /

-0.325 (-0.61%)

ASO Academy Sports
$49.31 /

+1.015 (+2.10%)

Hot Stocks
Cathie Wood's ARK Investment bought 330.4K shares of Verve Therapeutics today  20:19
12/06/22
12/06
20:19
12/06/22
20:19
VERV

Verve Therapeutics

$21.08 /

-0.32 (-1.50%)

 
ShowHide Related Items >><<
VERV Verve Therapeutics
$21.08 /

-0.32 (-1.50%)

VERV Verve Therapeutics
$21.08 /

-0.32 (-1.50%)

12/05/22 Stifel
Verve FDA request 'provides fodder for both bulls and bears,' says Stifel
12/02/22 Guggenheim
Beam hold being lifted 'encouraging' for Verve Therapeutics, says Guggenheim
10/06/22 Credit Suisse
Verve Therapeutics initiated with a Neutral at Credit Suisse
08/24/22 Stifel
Verve Therapeutics upgraded to Buy at Stifel on upside from near-term catalysts
VERV Verve Therapeutics
$21.08 /

-0.32 (-1.50%)

  • 21
    Jul
VERV Verve Therapeutics
$21.08 /

-0.32 (-1.50%)

Hot Stocks
AT&T COO says company continues to see healthy demand » 19:58
12/06/22
12/06
19:58
12/06/22
19:58
T

AT&T

$19.16 /

+0.425 (+2.27%)

COO Jeff McElfresh spoke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
T AT&T
$19.16 /

+0.425 (+2.27%)

T AT&T
$19.16 /

+0.425 (+2.27%)

11/14/22 Wells Fargo
Dycom price target lowered to $120 from $130 at Wells Fargo
10/24/22 Raymond James
AT&T upgraded to Strong Buy from Outperform at Raymond James
10/24/22 Barclays
AT&T price target raised to $19 from $18 at Barclays
10/24/22 Raymond James
AT&T upgraded to Strong Buy from Outperform at Raymond James
T AT&T
$19.16 /

+0.425 (+2.27%)

T AT&T
$19.16 /

+0.425 (+2.27%)

T AT&T
$19.16 /

+0.425 (+2.27%)

T AT&T
$19.16 /

+0.425 (+2.27%)

Periodicals
Apollo, Pimco sign deal to act together in Carvana debt talks, Bloomberg says » 19:37
12/06/22
12/06
19:37
12/06/22
19:37
CVNA

Carvana

$6.70 /

-0.4 (-5.63%)

, APO

Apollo Global

$63.20 /

-1.28 (-1.99%)

, BLK

BlackRock

$710.50 /

+1.6 (+0.23%)

, ARES

Ares Management

$72.27 /

-0.2 (-0.28%)

Apollo (APO) and Pimco…

Apollo (APO) and Pimco have signed an agreement to avoid a creditor battle as they hold negotiations with Carvana (CVNA) regarding its debt, Bloomberg's Davide Scigliuzzo and Eliza Ronalds-Hannon report, citing people familiar with the matter. The group, which also includes Blackrock (BLK), Ares Management (ARES), and Knighthead Capital, intends to operate with a "united front" on negotiations around Carvana debt restructuring or new financing, the report states.

ShowHide Related Items >><<
CVNA Carvana
$6.70 /

-0.4 (-5.63%)

BLK BlackRock
$710.50 /

+1.6 (+0.23%)

ARES Ares Management
$72.27 /

-0.2 (-0.28%)

APO Apollo Global
$63.20 /

-1.28 (-1.99%)

CVNA Carvana
$6.70 /

-0.4 (-5.63%)

11/30/22 BofA
BofA downgrades Carvana to Neutral on liquidity concerns
11/30/22 BofA
Carvana downgraded to Neutral from Buy at BofA
11/22/22 Baird
Carvana downgraded to Neutral from Outperform at Baird
11/21/22 Cowen
Carvana downgraded to Market Perform from Outperform at Cowen
APO Apollo Global
$63.20 /

-1.28 (-1.99%)

11/15/22 Deutsche Bank
Apollo Global price target raised to $83 from $81 at Deutsche Bank
11/03/22 Barclays
Apollo Global price target raised to $73 from $65 at Barclays
11/03/22 Deutsche Bank
Apollo Global price target raised to $81 from $78 at Deutsche Bank
10/19/22 UBS
Apollo Global price target lowered to $55 from $60 at UBS
BLK BlackRock
$710.50 /

+1.6 (+0.23%)

11/15/22 Deutsche Bank
BlackRock price target raised to $846 from $642 at Deutsche Bank
10/18/22 Credit Suisse
BlackRock initiated with a Neutral at Credit Suisse
10/14/22 BMO Capital
BlackRock price target lowered to $481 from $495 at BMO Capital
10/14/22 JPMorgan
BlackRock price target lowered to $666 from $716 at JPMorgan
ARES Ares Management
$72.27 /

-0.2 (-0.28%)

11/15/22 UBS
Ares Management price target raised to $95 from $78 at UBS
11/14/22 BMO Capital
Ares Management downgraded to Market Perform from Outperform at BMO Capital
11/01/22 RBC Capital
Ares Management price target raised to $93 from $83 at RBC Capital
10/28/22 Barclays
Ares Management price target raised to $90 from $80 at Barclays
CVNA Carvana
$6.70 /

-0.4 (-5.63%)

BLK BlackRock
$710.50 /

+1.6 (+0.23%)

ARES Ares Management
$72.27 /

-0.2 (-0.28%)

APO Apollo Global
$63.20 /

-1.28 (-1.99%)

  • 22
    Apr
CVNA Carvana
$6.70 /

-0.4 (-5.63%)

BLK BlackRock
$710.50 /

+1.6 (+0.23%)

ARES Ares Management
$72.27 /

-0.2 (-0.28%)

APO Apollo Global
$63.20 /

-1.28 (-1.99%)

CVNA Carvana
$6.70 /

-0.4 (-5.63%)

BLK BlackRock
$710.50 /

+1.6 (+0.23%)

ARES Ares Management
$72.27 /

-0.2 (-0.28%)

APO Apollo Global
$63.20 /

-1.28 (-1.99%)

CVNA Carvana
$6.70 /

-0.4 (-5.63%)

APO Apollo Global
$63.20 /

-1.28 (-1.99%)

On The Fly
Fly Intel: After-Hours Movers » 18:38
12/06/22
12/06
18:38
12/06/22
18:38
MDB

MongoDB

$144.73 /

-4 (-2.69%)

, GWRE

Guidewire

$56.67 /

-1.08 (-1.87%)

, CASY

Casey's General Stores

$230.07 /

-0.765 (-0.33%)

, SWBI

Smith & Wesson Brands

$11.80 /

-0.275 (-2.28%)

, SKIL

Skillsoft

$1.93 /

-0.06 (-3.02%)

, ZUO

Zuora

$7.20 /

-0.18 (-2.44%)

, HQY

HealthEquity

$65.82 /

-1.915 (-2.83%)

, PLAY

Dave & Buster's

$36.14 /

-1.115 (-2.99%)

, AVAV

AeroVironment

$85.20 /

-3.92 (-4.40%)

, SFIX

Stitch Fix

$3.66 /

-0.375 (-9.29%)

, TOL

Toll Brothers

$45.82 /

-1.09 (-2.32%)

, NBIX

Neurocrine

$120.26 /

-3.4 (-2.75%)

Check out this evening's…

ShowHide Related Items >><<
ZUO Zuora
$7.20 /

-0.18 (-2.44%)

TOL Toll Brothers
$45.82 /

-1.09 (-2.32%)

SWBI Smith & Wesson Brands
$11.80 /

-0.275 (-2.28%)

SKIL Skillsoft
$1.93 /

-0.06 (-3.02%)

SFIX Stitch Fix
$3.66 /

-0.375 (-9.29%)

PLAY Dave & Buster's
$36.14 /

-1.115 (-2.99%)

NBIX Neurocrine
$120.26 /

-3.4 (-2.75%)

MDB MongoDB
$144.73 /

-4 (-2.69%)

HQY HealthEquity
$65.82 /

-1.915 (-2.83%)

GWRE Guidewire
$56.67 /

-1.08 (-1.87%)

CASY Casey's General Stores
$230.07 /

-0.765 (-0.33%)

AVAV AeroVironment
$85.20 /

-3.92 (-4.40%)

MDB MongoDB
$144.73 /

-4 (-2.69%)

12/05/22 Baird
MongoDB price target lowered to $205 from $330 at Baird
11/29/22 UBS
MongoDB price target lowered to $200 from $390 at UBS
11/21/22 Morgan Stanley
MongoDB downgraded at Morgan Stanley amid challenging spending environment
11/21/22 KeyBanc
MongoDB initiated with an Overweight at KeyBanc
GWRE Guidewire
$56.67 /

-1.08 (-1.87%)

12/01/22 DA Davidson
Guidewire price target lowered to $90 from $96 at DA Davidson
12/01/22 JPMorgan
Guidewire initiated with an Overweight at JPMorgan
09/12/22 Citi
Guidewire price target lowered to $79 from $88 at Citi
09/08/22 Baird
Guidewire price target lowered to $81 from $99 at Baird
CASY Casey's General Stores
$230.07 /

-0.765 (-0.33%)

11/30/22 Wells Fargo
Casey's General Stores price target raised to $260 from $245 at Wells Fargo
11/29/22 Deutsche Bank
Casey's General Stores price target raised to $286 from $269 at Deutsche Bank
09/09/22 Deutsche Bank
Casey's General Stores price target lowered to $269 from $276 at Deutsche Bank
09/09/22 BMO Capital
Casey's General Stores price target raised to $250 from $235 at BMO Capital
SWBI Smith & Wesson Brands
$11.80 /

-0.275 (-2.28%)

09/09/22 Lake Street
Smith & Wesson Brands price target lowered to $22 from $26 at Lake Street
SKIL Skillsoft
$1.93 /

-0.06 (-3.02%)

10/12/22 Citi
Skillsoft price target lowered to $4.50 from $13.50 at Citi
09/08/22 DA Davidson
Skillsoft price target lowered to $3 from $7 at DA Davidson
09/06/22 B. Riley
Skillsoft price target lowered to $6 from $11 at B. Riley
07/26/22 Oppenheimer
Skillsoft assumed with a Perform at Oppenheimer
ZUO Zuora
$7.20 /

-0.18 (-2.44%)

11/28/22 Needham
Needham adds HubSpot to Conviction List, removes Zuora
10/21/22 Goldman Sachs
Zuora initiated with a Neutral at Goldman Sachs
08/25/22 Needham
Zuora price target lowered to $15 from $24 at Needham
08/25/22 Craig-Hallum
Zuora price target lowered to $16 from $22 at Craig-Hallum
HQY HealthEquity
$65.82 /

-1.915 (-2.83%)

12/05/22 RBC Capital
HealthEquity price target raised to $75 from $70 at RBC Capital
11/02/22 Jefferies
HealthEquity price target raised to $90 from $80 at Jefferies
10/21/22 Goldman Sachs
HealthEquity upgraded to Neutral from Sell at Goldman Sachs
10/11/22 BofA
AdaptHealth, HealthEquity, ViaSat added to 'Endeavor List' at BofA
PLAY Dave & Buster's
$36.14 /

-1.115 (-2.99%)

11/08/22 Deutsche Bank
Dave & Buster's upgraded to Buy from Hold at Deutsche Bank
10/05/22 Piper Sandler
Dave & Buster's price target lowered to $34 from $44 at Piper Sandler
09/09/22 Deutsche Bank
Dave & Buster's price target raised to $48 from $37 at Deutsche Bank
09/08/22 Truist
Dave & Buster's price target raised to $62 from $57 at Truist
AVAV AeroVironment
$85.20 /

-3.92 (-4.40%)

11/18/22 Canaccord
AeroVironment price target raised to $105 from $100 at Canaccord
11/10/22 Raymond James
AeroVironment upgraded to Outperform from Market Perform at Raymond James
11/10/22 Raymond James
AeroVironment upgraded to Outperform from Market Perform at Raymond James
09/30/22 RBC Capital
AeroVironment offers best small-cap exposure to Ukraine war, says RBC Capital
SFIX Stitch Fix
$3.66 /

-0.375 (-9.29%)

09/22/22 Barclays
Stitch Fix price target lowered to $5 from $7 at Barclays
09/21/22 Truist
Stitch Fix price target lowered to $6 from $8 at Truist
09/21/22 Evercore ISI
Stitch Fix price target lowered to $7 from $10 at Evercore ISI
09/21/22 MKM Partners
Stitch Fix price target lowered to $5 from $6 at MKM Partners
TOL Toll Brothers
$45.82 /

-1.09 (-2.32%)

11/22/22 JPMorgan
Toll Brothers upgraded to Overweight from Neutral at JPMorgan
10/21/22 Raymond James
Toll Brothers downgraded to Market Perform from Outperform at Raymond James
10/21/22 Raymond James
Toll Brothers downgraded to Market Perform from Outperform at Raymond James
09/19/22 KeyBanc
KeyBanc more bullish on homebuilder names, upgrades five stocks to Overweight
NBIX Neurocrine
$120.26 /

-3.4 (-2.75%)

11/14/22 Evercore ISI
Neurocrine downgraded to In Line from Outperform at Evercore ISI
11/02/22 BMO Capital
Neurocrine price target raised to $101 from $78 at BMO Capital
11/02/22 Wells Fargo
Neurocrine price target raised to $120 from $110 at Wells Fargo
11/02/22 RBC Capital
Neurocrine price target raised to $117 from $101 at RBC Capital
ZUO Zuora
$7.20 /

-0.18 (-2.44%)

TOL Toll Brothers
$45.82 /

-1.09 (-2.32%)

SWBI Smith & Wesson Brands
$11.80 /

-0.275 (-2.28%)

SKIL Skillsoft
$1.93 /

-0.06 (-3.02%)

SFIX Stitch Fix
$3.66 /

-0.375 (-9.29%)

PLAY Dave & Buster's
$36.14 /

-1.115 (-2.99%)

NBIX Neurocrine
$120.26 /

-3.4 (-2.75%)

MDB MongoDB
$144.73 /

-4 (-2.69%)

HQY HealthEquity
$65.82 /

-1.915 (-2.83%)

GWRE Guidewire
$56.67 /

-1.08 (-1.87%)

CASY Casey's General Stores
$230.07 /

-0.765 (-0.33%)

AVAV AeroVironment
$85.20 /

-3.92 (-4.40%)

TOL Toll Brothers
$45.82 /

-1.09 (-2.32%)

SWBI Smith & Wesson Brands
$11.80 /

-0.275 (-2.28%)

SFIX Stitch Fix
$3.66 /

-0.375 (-9.29%)

ZUO Zuora
$7.20 /

-0.18 (-2.44%)

TOL Toll Brothers
$45.82 /

-1.09 (-2.32%)

SWBI Smith & Wesson Brands
$11.80 /

-0.275 (-2.28%)

SKIL Skillsoft
$1.93 /

-0.06 (-3.02%)

SFIX Stitch Fix
$3.66 /

-0.375 (-9.29%)

PLAY Dave & Buster's
$36.14 /

-1.115 (-2.99%)

NBIX Neurocrine
$120.26 /

-3.4 (-2.75%)

MDB MongoDB
$144.73 /

-4 (-2.69%)

HQY HealthEquity
$65.82 /

-1.915 (-2.83%)

GWRE Guidewire
$56.67 /

-1.08 (-1.87%)

AVAV AeroVironment
$85.20 /

-3.92 (-4.40%)

ZUO Zuora
$7.20 /

-0.18 (-2.44%)

TOL Toll Brothers
$45.82 /

-1.09 (-2.32%)

SWBI Smith & Wesson Brands
$11.80 /

-0.275 (-2.28%)

SFIX Stitch Fix
$3.66 /

-0.375 (-9.29%)

PLAY Dave & Buster's
$36.14 /

-1.115 (-2.99%)

MDB MongoDB
$144.73 /

-4 (-2.69%)

Syndicate
X4 Pharmaceuticals announces common stock, warrant offering, no amount given » 18:27
12/06/22
12/06
18:27
12/06/22
18:27
XFOR

X4 Pharmaceuticals

$1.18 /

-0.11 (-8.53%)

X4 Pharmaceuticals…

X4 Pharmaceuticals announced that it has commenced an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares of its common stock. Piper Sandler, Stifel and Cantor are acting as joint book-running managers for the offering.

ShowHide Related Items >><<
XFOR X4 Pharmaceuticals
$1.18 /

-0.11 (-8.53%)

XFOR X4 Pharmaceuticals
$1.18 /

-0.11 (-8.53%)

11/30/22 H.C. Wainwright
X4 Pharmaceuticals price target raised to $5 from $3.50 at H.C. Wainwright
08/05/22 H.C. Wainwright
X4 Pharmaceuticals price target lowered to $3.50 from $8.50 at H.C. Wainwright
05/19/22 B. Riley
X4 Pharmaceuticals price target lowered to $7 from $10 at B. Riley
05/13/22 H.C. Wainwright
X4 Pharmaceuticals price target lowered to $8.50 from $11 at H.C. Wainwright
XFOR X4 Pharmaceuticals
$1.18 /

-0.11 (-8.53%)

XFOR X4 Pharmaceuticals
$1.18 /

-0.11 (-8.53%)

Hot Stocks
Guaranty Bancshares director Baker buys 21,536 common shares » 18:04
12/06/22
12/06
18:04
12/06/22
18:04
GNTY

Guaranty Bancshares

$34.54 /

-0.06 (-0.17%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNTY Guaranty Bancshares
$34.54 /

-0.06 (-0.17%)

07/07/22 Raymond James
Guaranty Bancshares downgraded to Market Perform from Outperform at Raymond James
07/07/22 Raymond James
Guaranty Bancshares downgraded to Market Perform from Outperform at Raymond James
GNTY Guaranty Bancshares
$34.54 /

-0.06 (-0.17%)

GNTY Guaranty Bancshares
$34.54 /

-0.06 (-0.17%)

Hot Stocks
MediciNova presents results from subgroup analysis of Phase 2 study of MN-001 » 18:03
12/06/22
12/06
18:03
12/06/22
18:03
MNOV

MediciNova

$2.40 /

-0.09 (-3.61%)

MediciNova announced that…

MediciNova announced that its Chief Medical Officer, Kazuko Matsuda, presented positive results from a subgroup analysis of the completed Phase 2 clinical trial which evaluated MN-001 for the treatment of hypertriglyceridemia at the International Diabetes Federation World Diabetes Congress 2022 held online December 5 - 8. In the completed Phase 2 study, MN-001 significantly reduced serum triglycerides in participants with non-alcoholic fatty liver disease and hypertriglyceridemia. Subsequent in vitro results revealed that MN-001, or tipelukast, downregulated CD36 and upregulated ABCG1 mRNA expression, both of which are highly associated with Type 2 diabetes mellitus. Hypothesizing that MN-001 might be more effective at reducing serum triglycerides in participants with a dual diagnosis of NAFLD and Type 2 diabetes mellitus, a subgroup analysis was conducted in participants with and without T2DM. Compared to subjects without T2DM, the T2DM group showed a greater reduction in serum triglyceride levels at Week 8, 50.8% reduction for with T2DM versus 17.8% reduction for without T2DM, p&#61;0.098.

ShowHide Related Items >><<
MNOV MediciNova
$2.40 /

-0.09 (-3.61%)

MNOV MediciNova
$2.40 /

-0.09 (-3.61%)

01/24/22 B. Riley
MediciNova price target lowered to $6 from $11 at B. Riley
MNOV MediciNova
$2.40 /

-0.09 (-3.61%)

Initiation
Argenx initiated with an Outperform at William Blair » 17:56
12/06/22
12/06
17:56
12/06/22
17:56
ARGX

Argenx

$384.77 /

-8.435 (-2.15%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARGX Argenx
$384.77 /

-8.435 (-2.15%)

ARGX Argenx
$384.77 /

-8.435 (-2.15%)

15:50 Today Barclays
Argenx price target raised to EUR 450 from EUR 405 at Barclays
11/14/22 JPMorgan
Argenx price target raised to EUR 480 from EUR 470 at JPMorgan
10/28/22 H.C. Wainwright
Argenx price target raised to $440 from $425 at H.C. Wainwright
10/27/22 Piper Sandler
Piper Sandler remains a buyer of Argenx after Q3 beat
ARGX Argenx
$384.77 /

-8.435 (-2.15%)

  • 24
    Mar
Downgrade
Gossamer Bio downgraded to Neutral from Outperform at SMBC Nikko » 17:54
12/06/22
12/06
17:54
12/06/22
17:54
GOSS

Gossamer Bio

$2.35 /

-6.97 (-74.79%)

SMBC Nikko analyst David…

SMBC Nikko analyst David Hoang downgraded Gossamer Bio to Neutral from Outperform with a $3 price target.

ShowHide Related Items >><<
GOSS Gossamer Bio
$2.35 /

-6.97 (-74.79%)

GOSS Gossamer Bio
$2.35 /

-6.97 (-74.79%)

11:06 Today Piper Sandler
Piper says 'Street overreacted' to Gossamer data, seralutinib still 'promising'
09:45 Today BTIG
Aerovate upgraded to Buy at BTIG after Gossamer study hits endpoint
10/20/22 Goldman Sachs
Gossamer Bio initiated with a Buy at Goldman Sachs
10/13/22 H.C. Wainwright
Gossamer Bio price target raised to $25 from $20 at H.C. Wainwright
GOSS Gossamer Bio
$2.35 /

-6.97 (-74.79%)

GOSS Gossamer Bio
$2.35 /

-6.97 (-74.79%)

Periodicals
U.K. game sales down 7.3% y/y in November, Gamesindustry.biz says » 17:48
12/06/22
12/06
17:48
12/06/22
17:48
ATVI

Activision Blizzard

$76.12 /

-0.215 (-0.28%)

, SONY

Sony

$79.45 /

-2.205 (-2.70%)

, EA

Electronic Arts

$127.44 /

-3 (-2.30%)

, NTDOY

Nintendo

$10.43 /

+0.09 (+0.87%)

, SGAMY

Sega Sammy Holdings

$3.24 /

-0.015 (-0.46%)

More than 4.3M video game…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SONY Sony
$79.45 /

-2.205 (-2.70%)

SGAMY Sega Sammy Holdings
$3.24 /

-0.015 (-0.46%)

NTDOY Nintendo
$10.43 /

+0.09 (+0.87%)

EA Electronic Arts
$127.44 /

-3 (-2.30%)

ATVI Activision Blizzard
$76.12 /

-0.215 (-0.28%)

ATVI Activision Blizzard
$76.12 /

-0.215 (-0.28%)

07:02 Today Edward Jones
Activision Blizzard upgraded to Buy from Hold at Edward Jones
12/01/22 Wedbush
Activision Blizzard added to Best Ideas List at Wedbush
11/28/22 JPMorgan
Activision Blizzard price target lowered to $86 from $95 at JPMorgan
11/28/22 Wells Fargo
Wells Fargo upgrades Activision Blizzard to Overweight with $95 price target
SONY Sony
$79.45 /

-2.205 (-2.70%)

11/02/22 Cowen
Sony price target lowered to $102 from $144 at Cowen
10/13/22 Oppenheimer
Oppenheimer sees more difficulty for Microsoft/Activision to win CMA approval
09/07/22 Goldman Sachs
Sony resumed with a Neutral at Goldman Sachs
07/08/22 Macquarie
Sony upgraded to Outperform, added to 'Marquee Buy' list at Macquarie
EA Electronic Arts
$127.44 /

-3 (-2.30%)

11/28/22 Truist
Electronic Arts price target lowered to $150 from $154 at Truist
11/22/22 Truist
EA's Sports College Football timeline 'consistent' with model, says Truist
11/08/22 Deutsche Bank
Electronic Arts remains top pick in video games at Deutsche Bank
11/02/22 Wedbush
Electronic Arts price target lowered to $164 from $170 at Wedbush
NTDOY Nintendo
$10.43 /

+0.09 (+0.87%)

09/07/22 Goldman Sachs
Nintendo resumed with a Buy at Goldman Sachs
05/24/22 CLSA
Nintendo price target lowered to 51,000 yen from 53,000 yen at CLSA
03/23/22 Macquarie
Nintendo upgraded to Outperform from Neutral at Macquarie
02/16/22 Jefferies
Nintendo upgraded to Buy from Hold at Jefferies
SGAMY Sega Sammy Holdings
$3.24 /

-0.015 (-0.46%)

SONY Sony
$79.45 /

-2.205 (-2.70%)

NTDOY Nintendo
$10.43 /

+0.09 (+0.87%)

EA Electronic Arts
$127.44 /

-3 (-2.30%)

ATVI Activision Blizzard
$76.12 /

-0.215 (-0.28%)

SONY Sony
$79.45 /

-2.205 (-2.70%)

SGAMY Sega Sammy Holdings
$3.24 /

-0.015 (-0.46%)

EA Electronic Arts
$127.44 /

-3 (-2.30%)

ATVI Activision Blizzard
$76.12 /

-0.215 (-0.28%)

SONY Sony
$79.45 /

-2.205 (-2.70%)

SGAMY Sega Sammy Holdings
$3.24 /

-0.015 (-0.46%)

EA Electronic Arts
$127.44 /

-3 (-2.30%)

ATVI Activision Blizzard
$76.12 /

-0.215 (-0.28%)

SONY Sony
$79.45 /

-2.205 (-2.70%)

EA Electronic Arts
$127.44 /

-3 (-2.30%)

ATVI Activision Blizzard
$76.12 /

-0.215 (-0.28%)

Hot Stocks
BAE Systems awarded $128.21M Army contract » 17:46
12/06/22
12/06
17:46
12/06/22
17:46
BAESY

BAE Systems

$40.45 /

+0.182 (+0.45%)

BAE Systems was awarded a…

BAE Systems was awarded a $128.21M firm-fixed-price contract for production of M88A2s. Bids were solicited via the internet with one received. Work will be performed in York, Pennsylvania, with an estimated completion date of March 31, 2025. FY10 Foreign Military Sales funds in the amount of $128.21M were obligated at the time of the award. U.S. Army Contracting Command is the contracting activity.

ShowHide Related Items >><<
BAESY BAE Systems
$40.45 /

+0.182 (+0.45%)

BAESY BAE Systems
$40.45 /

+0.182 (+0.45%)

11/07/22 JPMorgan
BAE Systems price target raised to 1,100 GBp from 1,000 GBp at JPMorgan
11/07/22 Redburn
BAE Systems initiated with a Buy at Redburn
10/07/22 JPMorgan
BAE Systems price target raised to 1,000 GBp from 965 GBp at JPMorgan
08/05/22 Deutsche Bank
BAE Systems price target raised to EUR 970 from EUR 860 at Deutsche Bank
BAESY BAE Systems
$40.45 /

+0.182 (+0.45%)

BAESY BAE Systems
$40.45 /

+0.182 (+0.45%)

Hot Stocks
Bell Textron awarded $1.36B Army contract » 17:44
12/06/22
12/06
17:44
12/06/22
17:44
TXT

Textron

$73.58 /

+3.585 (+5.12%)

Bell Textron was awarded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TXT Textron
$73.58 /

+3.585 (+5.12%)

TXT Textron
$73.58 /

+3.585 (+5.12%)

09:26 Today Morgan Stanley
Textron's FLRAA win should be 'positively received,' says Morgan Stanley
12/05/22 Jefferies
Textron award estimated at $11 per share net present value, says Jefferies
09/13/22 Bernstein
Textron initiated with a Market Perform at Bernstein
07/29/22 Susquehanna
Textron price target lowered to $84 from $90 at Susquehanna
TXT Textron
$73.58 /

+3.585 (+5.12%)

TXT Textron
$73.58 /

+3.585 (+5.12%)

TXT Textron
$73.58 /

+3.585 (+5.12%)

TXT Textron
$73.58 /

+3.585 (+5.12%)

Hot Stocks
BRT Apartments CEO buys $285K in common stock » 17:40
12/06/22
12/06
17:40
12/06/22
17:40
BRT

BRT Apartments

$19.84 /

+0.04 (+0.20%)

In a regulatory filing,…

In a regulatory filing, BRT Apartments disclosed that its CEO Jeffrey Gould bought 14.3K shares of common stock on December 6th in a total transaction size of $285K.

ShowHide Related Items >><<
BRT BRT Apartments
$19.84 /

+0.04 (+0.20%)

BRT BRT Apartments
$19.84 /

+0.04 (+0.20%)

11/11/22 B. Riley
BRT Apartments price target lowered to $30 from $32 at B. Riley
05/09/22 BTIG
BRT Apartments assumed with a Neutral at BTIG
03/21/22 B. Riley
BRT Apartments upgraded to Buy on strategic shift at B. Riley
03/21/22 B. Riley
BRT Apartments upgraded to Buy from Neutral at B. Riley
BRT BRT Apartments
$19.84 /

+0.04 (+0.20%)

Initiation
Sachem Capital initiated with a Hold at JonesTrading » 17:37
12/06/22
12/06
17:37
12/06/22
17:37
SACH

Sachem Capital

$3.41 /

-0.045 (-1.30%)

JonesTrading analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SACH Sachem Capital
$3.41 /

-0.045 (-1.30%)

SACH Sachem Capital
$3.41 /

-0.045 (-1.30%)

12/05/22 EF Hutton
Sachem Capital assumed with a Buy at EF Hutton
11/14/22 JMP Securities
Sachem Capital initiated with a Market Perform at JMP Securities
04/27/22 Oppenheimer
Sachem Capital initiated with an Outperform at Oppenheimer
SACH Sachem Capital
$3.41 /

-0.045 (-1.30%)

Hot Stocks
Kairos Acquisition announces liquidation » 17:30
12/06/22
12/06
17:30
12/06/22
17:30
KAIR

Kairos Acquisition

$10.07 /

+ (+0.00%)

Kairos Acquisition…

Kairos Acquisition "announced that, due to its inability to consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association, the Company intends to dissolve and liquidate in accordance with the provisions of its Charter, effective as of the close of business on December 6, 2022, and will redeem all of the outstanding shares of Class A common stock that were included in the units issued in its initial public offering, at a per-share redemption price of approximately $10.08."

Syndicate
HP Inc. files automatic mixed securities shelf  17:28
12/06/22
12/06
17:28
12/06/22
17:28
HPQ

HP Inc.

$28.31 /

-0.91 (-3.11%)

 
ShowHide Related Items >><<
HPQ HP Inc.
$28.31 /

-0.91 (-3.11%)

HPQ HP Inc.
$28.31 /

-0.91 (-3.11%)

11/23/22 Evercore ISI
Evercore sticking with In Line rating on HP Inc. as company takes 'right steps'
11/23/22 Citi
HP Inc. restructuring 'unexpected major positive,' says Citi
11/23/22 Barclays
HP Inc. price target lowered to $24 from $27 at Barclays
11/18/22 BofA
HP Inc. price target lowered to $27 from $30 at BofA
HPQ HP Inc.
$28.31 /

-0.91 (-3.11%)

HPQ HP Inc.
$28.31 /

-0.91 (-3.11%)

HPQ HP Inc.
$28.31 /

-0.91 (-3.11%)

Hot Stocks
Stitch Fix says will reduce marketing in back half of the year » 17:28
12/06/22
12/06
17:28
12/06/22
17:28
SFIX

Stitch Fix

$3.66 /

-0.375 (-9.29%)

Says retail industry…

Says retail industry experienced pull forward in Q1, which continues to be more pronounced than expected. Says will reduce marketing in back half of the year. Says advertising was 9% of revenue in Q1. Says for remainder of the year expects advertising to be 5%-6% of revenue, lower due to marketing shift. Says unit and order economics continue to be strong. Says quarter-over-quarter average selling price increased by a few basis points Comments taken from Q1 earnings conference call.

ShowHide Related Items >><<
SFIX Stitch Fix
$3.66 /

-0.375 (-9.29%)

SFIX Stitch Fix
$3.66 /

-0.375 (-9.29%)

09/22/22 Barclays
Stitch Fix price target lowered to $5 from $7 at Barclays
09/21/22 Truist
Stitch Fix price target lowered to $6 from $8 at Truist
09/21/22 Evercore ISI
Stitch Fix price target lowered to $7 from $10 at Evercore ISI
09/21/22 MKM Partners
Stitch Fix price target lowered to $5 from $6 at MKM Partners
SFIX Stitch Fix
$3.66 /

-0.375 (-9.29%)

SFIX Stitch Fix
$3.66 /

-0.375 (-9.29%)

SFIX Stitch Fix
$3.66 /

-0.375 (-9.29%)

SFIX Stitch Fix
$3.66 /

-0.375 (-9.29%)

Hot Stocks
Pulse Biosciences CFO Sandra Gardiner to resign » 17:27
12/06/22
12/06
17:27
12/06/22
17:27
PLSE

Pulse Biosciences

$2.65 /

+0.44 (+19.91%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLSE Pulse Biosciences
$2.65 /

+0.44 (+19.91%)

PLSE Pulse Biosciences
$2.65 /

+0.44 (+19.91%)

09/21/22 Maxim
Pulse Biosciences downgraded to Hold from Buy at Maxim
05/13/22 H.C. Wainwright
Pulse Biosciences downgraded to Neutral from Buy at H.C. Wainwright
05/12/22 Stephens
Pulse Biosciences downgraded to Equal Weight from Overweight at Stephens
04/01/22 H.C. Wainwright
Pulse Biosciences price target lowered to $8.50 from $20 at H.C. Wainwright
PLSE Pulse Biosciences
$2.65 /

+0.44 (+19.91%)

Periodicals
Apple CEO Tim Cook reaffirms company will use chips made in Arizona, AI says » 17:25
12/06/22
12/06
17:25
12/06/22
17:25
AAPL

Apple

$142.94 /

-3.67 (-2.50%)

, TSM

TSMC

$79.59 /

-2.06 (-2.52%)

Apple (AAPL) CEO Tim Cook…

Apple (AAPL) CEO Tim Cook backed up previous comments on Tuesday at an Arizona event, by reiterating that the iPhone maker will be using chips made in Arizona, wrote Andrew Orr for Apple Insider. Following Taiwan Semiconductor Manufacturing Company (TSM) or TSMC 's announcement " it would increase its Arizona investment, Apple CEO Tim Cook confirmed that the company would use chips built in the state," added the AI story. Reference Link

ShowHide Related Items >><<
TSM TSMC
$79.59 /

-2.06 (-2.52%)

AAPL Apple
$142.94 /

-3.67 (-2.50%)

AAPL Apple
$142.94 /

-3.67 (-2.50%)

11:24 Today UBS
Apple iPhone 14 Pro/Pro Max delivery times finally easing, says UBS
12/05/22 Wedbush
Apple shift out of China will not be easy, says Wedbush
12/02/22 Morgan Stanley
Morgan Stanley sees December quarter App Store forecast as 'conservative'
12/01/22 Piper Sandler
Apple estimates lowered on shutdowns in Zhengzhou at Piper Sandler
TSM TSMC
$79.59 /

-2.06 (-2.52%)

11/18/22 Erste Group
TSMC upgraded to Buy from Hold at Erste Group
11/15/22 Credit Suisse
Intel assumed with a Neutral at Credit Suisse
10/17/22 Northland
Teradyne price target lowered to $74 from $85 at Northland
10/13/22 Goldman Sachs
TSMC downgraded to Buy from Conviction Buy at Goldman Sachs
TSM TSMC
$79.59 /

-2.06 (-2.52%)

AAPL Apple
$142.94 /

-3.67 (-2.50%)

TSM TSMC
$79.59 /

-2.06 (-2.52%)

AAPL Apple
$142.94 /

-3.67 (-2.50%)

TSM TSMC
$79.59 /

-2.06 (-2.52%)

AAPL Apple
$142.94 /

-3.67 (-2.50%)

TSM TSMC
$79.59 /

-2.06 (-2.52%)

AAPL Apple
$142.94 /

-3.67 (-2.50%)

Conference/Events
BTIG medical technology analyst to hold a group dinner » 17:25
12/06/22
12/06
17:25
12/06/22
17:25

Medical Tech &…

Medical Tech & Digital Health Analysts Zimmerman and Thibault holds a group dinner meeting in New York on December 6 at 6:30 pm hosted by BTIG.

Recommendations
Airbus price target lowered to EUR 132 from EUR 140 at Jefferies » 17:18
12/06/22
12/06
17:18
12/06/22
17:18
EADSY

Airbus

$28.58 /

-0.185 (-0.64%)

Jefferies analyst Chloe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EADSY Airbus
$28.58 /

-0.185 (-0.64%)

EADSY Airbus
$28.58 /

-0.185 (-0.64%)

11/07/22 Redburn
Safran initiated with a Buy at Redburn
11/07/22 Redburn
Airbus initiated with a Buy at Redburn
11/01/22 JPMorgan
Airbus price target raised to EUR 185 from EUR 155 at JPMorgan
09/26/22 JPMorgan
Airbus price target lowered to EUR 155 from EUR 175 at JPMorgan
EADSY Airbus
$28.58 /

-0.185 (-0.64%)

EADSY Airbus
$28.58 /

-0.185 (-0.64%)

EADSY Airbus
$28.58 /

-0.185 (-0.64%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.